Improving use of ACE inhibitors in diabetic nephropathy. - Suppr | 超能文献

Improving use of ACE inhibitors in diabetic nephropathy.

作者信息

Gold J A

机构信息

Preventive Medicine and Health Policy Institute, Medical College of Wisconsin, Madison, USA.

出版信息

Wis Med J. 1996 Aug;95(8):588-9.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Improving use of ACE inhibitors in diabetic nephropathy.

Wis Med J. 1996 Aug;95(8):588-9.

2

ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy: is there a winner?

J Am Soc Nephrol. 2004 May;15(5):1358-60.

3

[Therapy of diabetic nephropathy. Effects of ACE inhibition on microcirculation].

Fortschr Med. 1997 Dec 20;115(35-36):26-9.

4

An evidence-based review of ACE inhibitors in incipient diabetic nephropathy.

Can J Clin Pharmacol. 2000 Summer;7(2):115-9.

5

Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.

Ethn Dis. 2002 Fall;12(4):S3-49-52.

6

Long-term ACE inhibitor therapy in diabetic nephropathy: potential hazard?

Diabet Med. 1998 Jun;15(6):524. doi: 10.1002/(SICI)1096-9136(199806)15:6<524::AID-DIA582>3.0.CO;2-U.

7

Why patients with diabetes, hypertension and/or proteinuria are not on angiotensin converting enzyme inhibitors.

Alaska Med. 1998 Jul-Sep;40(3):51-4.

8

Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.

Pharmacotherapy. 2005 Nov;25(11):1602-20. doi: 10.1592/phco.2005.25.11.1602.

9

Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.

J Hypertens Suppl. 1996 Dec;14(6):S11-4.

10

ARBs vs ACE inhibitors for preventing diabetic nephropathy.

J Fam Pract. 2005 May;54(5):453; discussion 453-4.

引用本文的文献

1

Indications for and utilization of ACE inhibitors in older individuals with diabetes. Findings from the National Health and Nutrition Examination Survey 1999 to 2002.

J Gen Intern Med. 2006 Apr;21(4):315-9. doi: 10.1111/j.1525-1497.2006.00351.x.

2

Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes.

J Gen Intern Med. 2004 Jun;19(6):669-75. doi: 10.1111/j.1525-1497.2004.30264.x.